OS Therapies Incorporated
Biotechnology
Healthcare
OSTX
21.25 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
2.24
52 week high
5.16
high
2.24
52 week low
0.00
low
2.14
growth
-36.21 %
previous Close
2.21
P/E ratio
market cap
67.99 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-4.54 M
99.88 %
eps
0.00 %
-4.17 %
eps surprise
-62.81 %
net profit margin
-453662200.00 %
0.00 %
operating incoming
-4.84 M
99.90 %
net change in cash
-168.99 K
93.41 %
cash on hand
2.80 M
-99.91 %
cost of revenue
0.00 %
top top